{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T16:38:12Z","timestamp":1740155892706,"version":"3.37.3"},"reference-count":29,"publisher":"Korean Cancer Association","issue":"3","license":[{"start":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T00:00:00Z","timestamp":1607558400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"funder":[{"DOI":"10.13039\/100016275","name":"Seoul National University Bundang Hospital","doi-asserted-by":"crossref","award":["02-2017-023"],"award-info":[{"award-number":["02-2017-023"]}],"id":[{"id":"10.13039\/100016275","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["e-crt.org"],"crossmark-restriction":true},"short-container-title":["Cancer Res Treat"],"published-print":{"date-parts":[[2021,7,15]]},"abstract":"<jats:p>Purpose This study aimed to evaluate the risk of cervical cancer diagnosed within 1 year after the last of multiple consecutive normal Papanicolau (Pap) tests.Materials and Methods The database of the National Health Insurance Service was used. We obtained Pap test data for 11,052,116 women aged 30-79 between 2007-2012. The cumulative incidence rates and 5-year overall survival rates of cervical cancer diagnosed within 1 year after the last normal Pap test were compared between women with one (N1), two (N2), and three consecutive normal Pap tests (N3). Women who did not receive a Pap test during the study period were assigned in the N0 group.Results The 1-year cumulative incidence rates of cervical cancer were 58.9, 24.6, 20.3, and 14.2 per 105 in the N0, N1, N2, and N3 groups, respectively. Compared to the N1 group, the risk of cervical cancer diagnosed within 1 year of the last normal Pap test decreased by 17% (relative risk [RR], 0.825; 95% confidence interval [CI], 0.716 to 0.951) in the N2 group and 42% (RR, 0.578; 95% CI, 0.480 to 0.695) in the N3 group. However, the 5-year survival rate in women diagnosed with cervical cancer within 1 year of the last normal Pap test in the N3 group was not higher than that of the N1 group (79.6% vs. 81.3%, p=0.706).Conclusion As normal Pap tests are consecutively repeated, cervical cancer risk significantly decreases. However, previous consecutive normal Pap tests are not associated with improving survival outcomes in women shortly diagnosed with cervical cancer after the last normal Pap test.<\/jats:p>","DOI":"10.4143\/crt.2020.826","type":"journal-article","created":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T02:27:08Z","timestamp":1608604028000},"page":"813-818","update-policy":"https:\/\/doi.org\/10.4143\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cervical Cancer in Women with Normal Papanicolaou Tests: A Korean Nationwide Cohort Study"],"prefix":"10.4143","volume":"53","author":[{"given":"Miseon","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyeongsu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Hoon","family":"Suh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong Beom","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2954","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21492"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2009.07.018"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11380"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2019.30.e38"},{"key":"ref5","first-page":"211","volume-title":"The diagnostic value of vaginal smears in carcinoma of the uterus 1941","author":"Papanicolaou","year":"1997"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2020.31.e31"},{"key":"ref7","first-page":"674","volume-title":"Screening for cervical cancer: US Preventive Services Task Force recommendation statement","author":"Curry","year":"2018"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1983.tb06449.x"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2105\/ajph.85.6.791"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1992.tb121599.x"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a117485"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-132-10-200005160-00009"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3109\/00016347709158352"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2015.26.3.232"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.16.2114"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0083100"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j504"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa035419"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1177\/096914139600300409"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2018.05.019"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9378(96)70013-3"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/cncy.21443"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20010225)93"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1258\/096914103771773302"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-0976.2001.005002094.x"},{"key":"ref26","first-page":"S56","volume-title":"Five-year risks of CIN 3+ and cervical cancer among women who test Pap-negative but are HPV-positive","author":"Katki","year":"2013"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9378(99)70256-5"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(80)90191-9"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.5413.874-c"}],"container-title":["Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/e-crt.org\/upload\/pdf\/crt-2020-826.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/e-crt.org\/journal\/view.php?doi=10.4143\/crt.2020.826","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/e-crt.org\/upload\/pdf\/crt-2020-826.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T00:43:20Z","timestamp":1626655400000},"score":1,"resource":{"primary":{"URL":"http:\/\/e-crt.org\/journal\/view.php?doi=10.4143\/crt.2020.826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,15]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,7]]}},"URL":"https:\/\/doi.org\/10.4143\/crt.2020.826","relation":{},"ISSN":["1598-2998","2005-9256"],"issn-type":[{"type":"print","value":"1598-2998"},{"type":"electronic","value":"2005-9256"}],"subject":[],"published":{"date-parts":[[2021,7,15]]},"assertion":[{"value":"2020-08-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-09","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-10","order":2,"name":"published","label":"Published online","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-15","order":3,"name":"published","label":"Print publication","group":{"name":"publication_history","label":"Publication History"}}]}}